Skip to main content
OpenTrials
Completed

NCT Number: NCT02866201

Etiological Diagnosis of Traveler's Diarrhoea

Traveler's diarrhoea or turista is the most common disease in travelers. It has been reported based on studies in 20 to 60% of travelers, depending among other conditions and travel destinations. Currently, less than 30% of the etiology of diarrhoea is identified by bacteriological v,irological and parasitology traditional techniques. This ignorance of the diarrhoea etiology causes difficulties in the establishment of a specific and rapid management in this extremely common condition and having a significant cost to society. Technological advances in laboratory diagnosis, such as quantitative real-time Polymerase Chain Reaction (PCR), can allow us now to improve the etiological diagnosis of traveler's diarrhoea using simple rectal swabs.

So, the principal objective of this study is to assess the efficacy of a new diagnosis strategy in order to establissh the etiological diagnosis of traveler's diarrhoea. The hypothesis consists in improving the number of patients with a confirmed etiological diagnosis of traveler's diarrhoea by 5%.

Completed

Looking for future studies?

Notify Me

Key information

Age range

18 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Assistance Publique Hopitaux de Marseille

Marseille, 13354, France

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Patient leaving for a trip outside France for a period (not exceeding 3 months)
  • Patient who get seen by Travel information Service at hospital before departure.
  • Adult patients (> 18 years).
  • Patient who freely signed the written informed consent
  • Patient affiliated to a social security regime. Exclusion criteria
  • Minor patient (<18 years)
  • Pregnant or nursing woman.
  • Adult patient under guardianship.
  • Patient deprivated with liberty under court order.
  • Patient refusing to sign the wrtten consent form

Treatment and study plan

Rectal Swab

Other

Primary outcomes

  1. Percentage of patients with a confirmed etiological diagnosis of traveler's diarrhoea

    Time frame: Up to 6 months

Sponsors and collaborators

Lead sponsor

Assistance Publique Hopitaux De Marseille

Other

Registry information

Acronym: DIAVOY

Important dates

Study start
2013
Primary completion
2019
Study completion
2022
First posted
Aug 15, 2016
Registry last updated
Apr 21, 2023

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.